ÂÜÀòÂÒÂ×

James Babcock is currently the Associate Director at Gilead Sciences. James has over 15 years of experience in the finance and accounting field. Prior to joining Gilead Sciences, they were the Senior Director Finance at Pulse Biosciences, Inc. from January 2019 to December 2020. There, they were responsible for leading the FP&A team supporting all business functions, developing and managing the company financial model, coordinating fund raising activities, helping implement Adaptive Planning and NetSuite, assisting with Auditors and SEC reporting, drafting Audit Committee and Board of Directors presentations, and leading cash management.

Babcock began their career at Puma Biotechnology, Inc. in January 2017 as the Associate Director of Finance. In this role, they were responsible for contracting from initial term sheets to final agreement execution, implementation, financial management & reporting. James was promoted to Director of Financial Planning and Analysis in January 2015 and held this position until December 2017.

James Babcock has earned both a Bachelor of Arts in Economics & Accounting from the University of California, Los Angeles as well as a Master of Business Administration from the University of California, Berkeley.